Recombinant proteins with the immunoreactivity of hepatitis B virus e antigen (HBeAg), a process for the preparation thereof and the use thereof in immunoassays and vaccines

US6277631A · kind A · utility

Assignee

• Dade Behring Marburg GmbH · DE

Inventors

• Michael Noah · Marburg, DE
• Michael Broker · Marburg, DE

Key dates

• Filing date: May 22, 1995
• Grant date: Aug 21, 2001
• Expiry date: May 22, 2015

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S530/826
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Recombinant yeast expression vectors with the features indicated in the patent claims are described. These recombinant yeast expression vectors can be used for the preparation of HBeAg in yeast host organisms. Appropriate expression systems, transformed host organisms, diagnostic aids and medicinal agents are additionally described.